Prostate Cancer - Results from #1600

Prostate-specific antigen (PSA) decline with apalutamide therapy is associated with longer survival and improved outcomes in individuals with metastatic prostate cancer: a plain language summary of the TITAN study. December 25, 2023

Incidental Discovery of Hepatocellular Carcinoma on 18F-PSMA PET CT Performed for Prostate Cancer Reassessment. December 25, 2023

First patient dosed in Clarity’s registrational Phase III prostate cancer trial with Cu-64 SAR-bisPSMA December 22, 2023

Poly(ADP-ribose) Polymerase Inhibitor Combinations in First-Line Metastatic Castration-Resistant Prostate Cancer: Increasing Toxicity With Unclear Benefits. December 22, 2023

Characterizing Referrals for Prostate Cancer Genetic Services in a Safety-Net Hospital. December 22, 2023

Real-world prevalence of homologous recombination repair mutations in advanced prostate cancer: an analysis of two clinico-genomic databases. December 22, 2023

The PENGUIN approach to reconstruct protein interactions at enhancer-promoter regions and its application to prostate cancer. December 22, 2023

Stimulated Raman Histology Interpretation by Artificial Intelligence Provides Near-Real-Time Pathologic Feedback for Unprocessed Prostate Biopsies. December 22, 2023

Clinical evaluation and treatment in men with low testosterone levels and prostate cancer. December 22, 2023

Prostate MRI and image quality: The urologist's perspective. December 22, 2023

Evaluation of the utility of rescans in the treatment of prostate and pelvic nodes with pencil beam scanning protons. December 22, 2023

Local Treatment and Treatment-Related Adverse Effects Among Patients With Advanced Prostate Cancer. December 22, 2023

FASN Gene Methylation is Associated with Fatty Acid Synthase Expression and Clinical-Genomic Features of Prostate Cancer. December 21, 2023

Intratumoural immunotherapy plus focal thermal ablation for localized prostate cancer. December 21, 2023

Therapy With Metronomic Cyclophosphamide (mCyc) for Previously-Treated Metastatic Castrate-Resistant Prostate Cancer (mCRPC). December 21, 2023

Performance of cognitive vs. image-guided fusion biopsy for detection of overall and clinically significant prostate cancer in a multiethnic population. December 21, 2023

Based on PI-RADS v2.1 combining PHI and ADC values to guide prostate biopsy in patients with PSA 4-20 ng/mL. December 21, 2023

RNA-Based Homologous Recombination Deficiency Signature Detects Homologous Recombination Deficiency-RNA+ Patients With and Without Homologous Recombination Repair Gene Pathogenic Alterations in Men With Prostate Cancer. December 21, 2023

PIM1 drives lipid droplet accumulation to promote proliferation and survival in prostate cancer. December 21, 2023

Citron Kinase Is a Druggable Target in Treatment-Resistant Prostate Cancer. December 21, 2023

Page 81 of 1435